(S)-Methyl 5-oxopyrrolidine-3-carboxylate

Catalog No. :
ACLIJH204
CAS No. :
428518-31-4
Molecular Formula :
C6H9NO3
Molecular Weight :
143.14

IUPAC Name:methyl (S)-5-oxopyrrolidine-3-carboxylate

(S)-Methyl 5-oxopyrrolidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$375.00Login to see priceIn stockInquiry
250mg95%$688.00Login to see priceIn stockInquiry
500mg95%$1250.00Login to see priceIn stockInquiry
1g95%$1875.00Login to see priceIn stockInquiry
5g95%$8331.00Login to see priceIn stockInquiry
10g95%$13913.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-Methyl 5-oxopyrrolidine-3-carboxylate
IUPAC Namemethyl (S)-5-oxopyrrolidine-3-carboxylate
MDL No.MFCD13194686
Molecular FormulaC6H9NO3
Molecular Weight143.14
SMILESO=C([C@@H](C1)CNC1=O)OC
InChI KeyFJRTVLWHONLTLA-BYPYZUCNSA-N
Synonym(S)-Methyl 5-oxopyrrolidine-3-carboxylate | 428518-31-4 | METHYL (3S)-5-OXOPYRROLIDINE-3-CARBOXYLATE | MFCD13194686 | AKOS006356841 | (S)-Methyl5-oxopyrrolidine-3-carboxylate | AS-70419 | Methyl (S)-5-Oxopyrrolidine-3-carboxylate | CS-0038415 | W11289 | A
CAS No.428518-31-4
PubChem CID40787012

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P261-P264-P270-P272-P280-P301+P312-P302+P352-P321-P330-P333+P313-P363-P501

Synthetic Route by SureRoute

1. ACLIJH204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIJH204 route product structure diagram
    ACLIJH204428518-31-4 In Stock
Inquiry

2. ACLIJH204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIJH204 route product structure diagram
    ACLIJH204428518-31-4 In Stock
Inquiry

Comments (0)